Phase Ib Study to Evaluate the Safety and Efficacy of TLL018 in Patients With Plaque Psoriasis
Status:
Not yet recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blind, placebo-controlled, multicenter clinical trial of
about 70 subjects with moderate to severe plaque psoriasis.